Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Update

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the target of a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 2,638 shares, an increase of 20.5% from the January 15th total of 2,189 shares. Based on an average trading volume of 921 shares, the short-interest ratio is currently 2.9 days. Based on an average trading volume of 921 shares, the short-interest ratio is currently 2.9 days.

Hikma Pharmaceuticals Stock Performance

HKMPY opened at $44.28 on Thursday. The business has a 50 day moving average price of $42.23 and a 200 day moving average price of $44.76. Hikma Pharmaceuticals has a twelve month low of $39.93 and a twelve month high of $59.26.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.